Expression of CC and CXC receptors on normal B lymphocytes and on malignant B cells obtained from patients with lymphoproliferative disorders
Patients . | CCR1 . | CCR2 . | CCR3 . | CCR5 . | CCR6 . | CXCR1 . | CXCR2 . | CXCR3 . | CXCR4 . | CXCR5 . |
|---|---|---|---|---|---|---|---|---|---|---|
| B-CLL | 9/13 | 6/13 | 13/13 | 1/13 | 13/13 | 3/13 | 0/13 | 13/13 | 13/13 | 13/13 |
| HCL | 4/9 | 6/9 | 7/9 | 7/9 | 9/9 | 4/9 | 2/9 | 3/9 | 9/9 | 9/9 |
| MCL | 0/5 | 3/5 | 2/5 | 5/5 | 5/5 | 0/5 | 0/5 | 2/5 | 5/5 | 5/5 |
| MZL | 0/5 | 0/5 | 0/5 | 3/5 | 5/5 | 2/5 | 2/5 | 5/5 | 5/5 | 4/5 |
| SLL | 0/6 | 1/6 | 1/6 | 3/6 | 6/6 | 3/6 | 4/6 | 4/6 | 6/6 | 3/6 |
| FCL | 0/5 | 2/5 | 0/5 | 4/5 | 1/5 | 2/5 | 2/5 | 4/5 | 5/5 | 5/5 |
| Normal B cells | 1/5 | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 0/5 | 2/5 | 5/5 | 5/5 |
Patients . | CCR1 . | CCR2 . | CCR3 . | CCR5 . | CCR6 . | CXCR1 . | CXCR2 . | CXCR3 . | CXCR4 . | CXCR5 . |
|---|---|---|---|---|---|---|---|---|---|---|
| B-CLL | 9/13 | 6/13 | 13/13 | 1/13 | 13/13 | 3/13 | 0/13 | 13/13 | 13/13 | 13/13 |
| HCL | 4/9 | 6/9 | 7/9 | 7/9 | 9/9 | 4/9 | 2/9 | 3/9 | 9/9 | 9/9 |
| MCL | 0/5 | 3/5 | 2/5 | 5/5 | 5/5 | 0/5 | 0/5 | 2/5 | 5/5 | 5/5 |
| MZL | 0/5 | 0/5 | 0/5 | 3/5 | 5/5 | 2/5 | 2/5 | 5/5 | 5/5 | 4/5 |
| SLL | 0/6 | 1/6 | 1/6 | 3/6 | 6/6 | 3/6 | 4/6 | 4/6 | 6/6 | 3/6 |
| FCL | 0/5 | 2/5 | 0/5 | 4/5 | 1/5 | 2/5 | 2/5 | 4/5 | 5/5 | 5/5 |
| Normal B cells | 1/5 | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 0/5 | 2/5 | 5/5 | 5/5 |
Number of positive cases of the subjects tested.